Trial intelligence / Profile preview

Effect of Betamethasone Phonophoresis in Treatment of Vitiligo

NCT07267273Recruiting

Sponsor
Cairo University
Start
Nov 2025
Primary completion
Feb 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Trial of betamethasone in Vitiligo (2 arms), sponsored by Cairo University. Primary endpoint: Vitiligo Management at 3 months. Started Nov 2025; status: recruiting.

02

Drugs

betamethasone
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT07267273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07267273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call